Previous Page  9 / 28 Next Page
Information
Show Menu
Previous Page 9 / 28 Next Page
Page Background

Page 52

Notes:

allied

academies

Cell Science, Stem Cell Research &

Pharmacological Regenerative Medicine

November 29-30, 2017 | Atlanta, USA

Annual Congress on

Adv cel sci tissue cul 2017 | Volume 1 Issue 2

Histopathological changes in male Wistar rats maintained on a water-based

Sutherlandia

frutescencs

extract

Nicolas John Wickens

Nelson Mandela University, South Africa

I

n this study, a standardized 46-week chronic drinking water

toxicity protocol was used to elucidate the toxic potential of

Sutherlandia frutescens

using histopathologic, morphometric

and transmission electron microscopic analysis. In this

study, the histopathologic changes in the duodenum, heart,

kidney, liver, lung, pancreas and spleen of male Wistar rats

was evaluated. Fifty-four rats were randomly divided into

four groups: Group 1–Normal diet control (ND control), n=7,

Group 2–Normal diet + plant extract (ND+p), n=9, Group 3–

High fat diet control (HFD control), n=19. Group 4–High fat

diet + p (HFD + p), n=19. In the high fat group male Wistar

rats were fed ±55 g/day of a specialized high fat diet over

a 46-week period to induce obesity and an insulin resistant

state. The treatment groups (groups 2 and 4) received a dose

concentration of a tea extract of the

S. frutescens

plant in their

drinking water daily. This study showed that the consumption

of

S. frutescens

significantly reduces weight gain per week in

male Wistar rats on a chronic high fat diet (p≤0.001 vs. HFD

control group).

S. frutescens

appears to propagate periportal

and centrilobular glycogen storage in rat hepatocytes in

the experimental groups as exemplified by a significantly

(p≤0.0001 vs. control groups) increased incidences of

Periodic Acid Schiff (PAS) positive staining.

S. frutescens

also

reduced intracellular lipid accumulation as made evident

by the significantly lower incidence of epicardial adipose

tissue (EAT), hepatic steatosis and pancreatic interstitial fat.

Obesity was associated with increased fibrotic lesions such

as myocardial perivascular fibrosis, centrilobular hepatic

fibrosis and pancreatic periductal fibrosis. In this study,

pulmonary infection was equally prevalent in all rats. Despite

the complex histopathology in all groups’ unique histopathology

such as a conservative PMNL infiltration, substantial intra-

alveolar oedema and focal arterial wall hypertrophy in the

control groups was highly suggestive of Sendai viral infection.

However, histopathologic evidence in the treatment groups,

suggested chronic recurrent viral infection with superimposed

Mycoplasma pulmonis

bacterial infection. The impact of

advanced suppurative pulmonary infection was widespread

and exemplified by increased lesion incidences of spontaneous

murine progressive cardiomyopathy (MCP) and spontaneous

chronic progressive nephropathy (CPN) among others. In

conclusion,

S. frutescens

administered for 46 weeks to male

Wistar rats significantly lowered intracellular lipid accumulation

and obesity associated myocardial, renal, hepatobiliary,

pulmonary andpancreatic histopathology.Moreover, duodenal,

cardiovascular, hepatobiliary, pulmonary, renal, pancreatic and

splenic tissue did not show histopathologic evidence of direct

plant extract associated carcinogenicity or toxicity.

Speaker Biography

Nicolas JohnWickens has completed his Doctorate from the NelsonMandela University

in South Africa. He is a Lecturer of Pathology and Histology in the Department of

Medical Laboratory Sciences in the Faculty of Health Sciences. After his pre-med

studies at the University of Stellenbosch, he went on to complete a Master’s degree in

Medical Laboratory Sciences at the Nelson Mandela University, where he was offered

a post as Lecturer in the department. During his Doctorate studies, he investigated

the histopathology found in male Wistar rats after chronic consumption of an extract

of the plant

Sutherlandia frutescencs

which is used in South Africa by the indigenous

people to lower blood sugar in patients with type 2 diabetes.

e:

nwickens@nmmu.ac.za